Pasithea Therapeutics Corp. (KTTA) has a market capitalization of $5.37M and trades at $0.72. The 52-week range is 0.281-3.79.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-2.91.
The stock has a beta of 0.20, operates in the Healthcare sector.
